In breast cancer cells, Orai1 and TRPC6 are upregulated in the estrogen receptor positive (ER+) and triple negative subtypes, and Orai3 is overexpressed exclusively in the ER+ breast cancer subtype [9,10]. Here, ESR1 is linked to breast cancer.